Search the web
Welcome, Guest
[Sign Out, My Account]
Morningstar_Inc.

Monday, August 29 2016 6:46pm ET - U.S. Markets Closed.
Industry Center - Drugs - Generic
Industry Center > Drugs - Generic
More On This Industry
Summary
·News
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
Top Industries
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Diversified Utilities
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
·Tobacco Products, Other
Complete Industry List...
Morningstar Inc.
In-depth Company Dossier Reports on over 7,500 publicly traded U.S. companies. Click here for your free report.
  
Industry Market Summary
Drugs - Generic
Composite Value: 0.0
Today's Change: +0.00%
S&P 500: +0.43%
chart for
[Drugs - Generic (^YHOh785)]
Drugs - Generic News
Mylan Announces Discount Generic EpiPen Following Backlash (MYL)
57 minutes ago (U.S.News & World Report)
Mylan N.V. (MYL) announced Monday it would release a generic version of its EpiPen auto-injector -- costing $300 -- following recent public backlash regarding its drug prices. "The launch of a generic EpiPen, which follows the steps we took last week on the brand to immediately reduce patients' out-of-pocket costs, will offer a long-term solution to further reduce costs and ease the burden and complexity of the process on the patient," Mylan CEO Heather Bresch says in a statement. The generic product will come in a two-pack carton in 0.15 mg and 0.30 mg options, and the company says it will still market and distribute the branded version.
Sophiris Bio Closes Underwritten Public Offering - (PR Newswire)
4-DAY DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Lipocine Inc. and Reminds Investors with Losses In Excess of $100,000 to Contact the Firm - ()
More News on Drugs - Generic: Latest News,
Industry Top Performers
Intraday Price Performance% ChangeMarket Cap
More Top Intraday Price Performers...
Market Capitalization% ChangeMarket Cap
ABBOTT LABORATORIES [ABT.L] 0.00% $6604.7 B
SUN PHARMACEUTICAL INDUSTRIES [SUNPHARMA.BO] +0.40% $1870.3 B
LUPIN LTD. [LUPIN.BO] -2.15% $710.7 B
LUPIN LIMITED [LUPIN.NS] -2.13% $681.3 B
DR.REDDYS LABORATORIES LTD. [DRREDDY.BO] +0.28% $601.4 B
More Top Companies by Market Cap...
More Top Performers: by Valuation, by Growth, by Financial Strength
Industry Calendar
Upcoming Events
Date Co Event
08/29/16 600518.SS Kangmei Pharmaceutical Co Ltd Q2 2016 Earnings Release
08/29/16 CTLT Catalent Inc Q4 2016 Earnings Release
08/30/16 600085.SS Beijing Tongrentang Co Ltd Q2 2016 Earnings Release
More Upcoming Events...
Recent Events
Date Co Event
08/23/16 LCI Lannett Co Inc Common Stock upside earnings surprise (+23.73%)
08/19/16 AGN Allergan plc Ordinary Shares upgraded by Mizuho
08/19/16 JNP Juniper Pharmaceuticals, Inc. downgraded by H.C. Wainwright
More Recent Events...
  
Locate Industry by Company
Enter Symbol:
Industry Statistics
Market Capitalization:10,614B
Price / Earnings:NM
Price / Book:-4.3
Net Profit Margin (mrq):-4.8%
Price To Free Cash Flow (mrq):-7.3
Return on Equity:0.0%
Total Debt / Equity:43.6
Dividend Yield:0.4%
View Industry Browser
Community Spotlight
Most Active Boards
Board Popularity
SRLS
GNVC
WPI
Unusually Active Boards
Board Variance
SRLS
GNVC
WPI

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drugs - Generic Headlines
More Finance RSS Feeds


Copyright © 2016 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2016 Morningstar, Inc. All Rights Reserved. Company information © 2016 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?